Oct 2026· Naunyn-Schmiedeberg's Archives of Pharmacology· 0 citations· 57 references
Medicine
TL;DR
Results indicate that multiple-epitope vaccine constructs have strong binding properties and are good candidates for developing a vaccine against HCV3a.
The construct is identified as a promising HCV vaccine candidate that now warrants experimental validation and normal mode analysis and molecular dynamics simulations were performed to assess its stability.
Mohammad-Matin Karbalaee-Alinazari, Ava Hashempour, Ali Honari Jahromi et al.· Human Immunology· 0 citations
The computational analyses support the proposed multi-epitope construct as a potential vaccine candidate against S. haemolyticus and provide a basis for its further experimental evaluation.
Background Hepatitis E virus (HEV) is one of the leading causes of acute and chronic hepatitis among humans across the globe and is linked to severe diseases in immunocompromised individuals and pregnant women. Despite its substantial global burden, only one vaccine is licensed (in China and Pakistan), limiting its glo...
Maham Mehrangaze Khonza, Zain Saeed, Zohra Jabeen et al.· Frontiers in Bioinformatics· 0 citations
A multi-epitope subunit vaccine (MESV) candidate using immunoinformatic approaches that targets five virulence-associated proteins and may elicit potent humoral and cellular immune responses against M. tuberculosis are viable options warranting further experimental validation.
Swagat Ranjan Maharana, S. Khan, Kiran Mahapatra et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.